Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 109

Sort by

Sort Order Select

Journal Articles

Heme Overload Triggers Xanthine Oxidase Release and Mediates the Inflammatory Response

Heidi M Schmidt, BSE, Eric Kelley, PhD, Adam Straub, PhD

Blood (2019) 134 (Supplement_1): 3529.

https://doi.org/10.1182/blood-2019-130274

Published: 2019

Journal Articles

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

Haiping He, MD PhD, Atsuko Takahashi, MT., Yuki Yamamoto, MT, Akiko Hori, Yuta Miharu, MT, Kazuaki Yokoyama, MD PhD, Miwako Narita, MD PhD, Fumitaka Nagamura, MD PhD, Arinobu Tojo, MD PhD, Tonghua Yang, MD PhD, Tokiko Nagamura-Inoue, MD PhD

Blood (2019) 134 (Supplement_1): 5011.

https://doi.org/10.1182/blood-2019-125046

Published: 2019

Journal Articles

The Factor VIII Variant X5 Enhances Hemophilia a Gene Therapy Efficiency By Its Improved Secretion

Franziska Horling, PhD, Johannes Lengler, PhD, Wenjing Cao, PhD, Biao Dong, PhD, Bagirath Gangadharan, Maurus De La Rosa, PhD, Werner Hoellriegl, PhD, Birgit M Reipert, PhD, Friedrich Scheiflinger, Weidong Xiao, PhD, Hanspeter Rottensteiner

Blood (2019) 134 (Supplement_1): 3356.

https://doi.org/10.1182/blood-2019-126489

Published: 2019

Journal Articles

A Direct Oral Anticoagulant Edoxaban Enhanced Fibrinolysis Via Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor Activation and Enhancement of Plasmin Generation in Human Plasma

Yoshiyuki Morishima, PhD, Yuko Honda, Taketoshi Furugohri, PhD

Blood (2018) 132 (Supplement 1): 3786.

https://doi.org/10.1182/blood-2018-99-109724

Published: 2018

Journal Articles

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Jia Yu, Xuan Yuan, MD MSc, Kang Zhou, Daniel White, Samuel A. Merrill, MD PhD, Robert A. Brodsky, MD

Blood (2018) 132 (Supplement 1): 3748.

https://doi.org/10.1182/blood-2018-99-119445

Published: 2018

Journal Articles

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Flora Peyvandi, MD PhD, Paolo Bucciarelli, MD, Carla Valsecchi, BSc, Marco Boscarino, Roberta Palla, PhD, Elena Santagostino, Amal El-Beshlawy, Mohsen Saleh Elalfy, MD, Vijay M. Ramanan, MBBS,MDDM, Peyman Eshghi, MD, Suresh Hanagavadi, MD, Mehran Karimi, MD, Cecil Ross, MD, Mamta V Manglani, MD, Guy Young, Tulika Seth, MDMBBS,FAAP, Shashikant Apte, MD FRCPA, Dinesh M Nayak, MD, Maria Elisa Mancuso, Johnny Mahlangu, Bonanad Santiago, MD, Monica H Cerqueira, MD PhD, Nadia P Ewing, MD, Christoph Male, MD, Tarek Owaidah, MDFRCPA, Veronica Soto Arellano, MD, Suvankar Majumdar, MBCHB, Mindy Simpson, MD, Mathew Thomas, MD, Ezio Zanon, Marilyn J Manco-Johnson, MD, Monica Martinez, MD, Maria Gabriella Mazzucconi, MD, Daniela Neme, MD, Rogelio Alejandro Paredes-Aguilera, MD, Alessandra N L Prezotti, MD MSc, Klaus Schmitt, MD, Bulent Zulfikar, Prof, Pier Mannuccio Mannucci, MD, Frits Richard Rosendaal, MD

Blood (2018) 132 (Supplement 1): 384.

https://doi.org/10.1182/blood-2018-99-114599

Published: 2018

Journal Articles

Histones Induce the Release of Extracellular Hemoglobin and Red Blood Cell-Derived Microvesicles with Procoagulant Activity

Denis Noubouossie, MD PhD, Juraj Sokol, MD PhD, Mark Gerard Piegore, BS, Anton Ilich, MD, Michael Wayne Henderson, MSc, Micah Mooberry, MD, Dougald Monroe, PhD, Nigel S. Key, MBChB, FRCP

Blood (2018) 132 (Supplement 1): 2514.

https://doi.org/10.1182/blood-2018-99-118769

Published: 2018

Journal Articles

Intravascular Cells and Circulating Microparticles Induce Procoagulant Activity Via Phosphatidylserine Exposure in Venous Thromboembolism and Contribute to Altered Plasma Fibrin Clot Properties

Yan Kou, MD, Lili Zou, MD, Hui Liang, MD, Li Hou, MD, Tao Li, MD, Yan Zhang, MD, Baorong LI, MD, Yingmiao LIU, MD, Cong Zhang, MD, Ruipeng Liu, MD, Xinyi Zhao, MD, Ying Wang, MD, Jiaqi Jin, MD, Yayan Bi, MD PhD, Jialan Shi, MD PhD, Junjie Kou, MD PhD

Blood (2018) 132 (Supplement 1): 2519.

https://doi.org/10.1182/blood-2018-99-115604

Published: 2018

Journal Articles

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

Tilman M. Hackeng, PhD, Peter van Doorn, MSc, Jan Rosing, PhD, Joost Meijers, PhD, Saskia Middeldorp, MD PhD, Paolo Simioni, MD PhD, Elisabetta Castoldi, PhD

Blood (2018) 132 (Supplement 1): 1168.

https://doi.org/10.1182/blood-2018-99-118767

Published: 2018

Journal Articles

Lesional Mechanism of Alpha Thalassemias : Towards a Common Mechanism Alpha Thal / Beta Thal

Serge Pissard, PhD, Flavia Guillem, PhD, Elisa Domingues-Hamdi, Michaël Dussiot, PhD, Thunwarat Suriyun, Olivier Hermine, MD PhD, Veronique Baudin creuza, Genevieve Courtois, PhD

Blood (2017) 130 (Supplement 1): 358.

https://doi.org/10.1182/blood.V130.Suppl_1.358.358

Published: 2017

Journal Articles

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Disease Severity

Amanda P. Waller, PhD, Katelyn J Wolfgang, Alisa S Wolberg, PhD, Bryce A. Kerlin, MD

Blood (2017) 130 (Supplement 1): 1072.

https://doi.org/10.1182/blood.V130.Suppl_1.1072.1072

Published: 2017

Journal Articles

Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria

Fraser Macrae, BSc, PhD, Polly Bowman, Emma Linton, Barnaby Peacock-Young, Deborah Clarke, MSc, Darren J Newton, PhD, Claire E McKinley, BSc, Kathryn Riley, Nicola Copeland, Louise Arnold, Morag Griffin, Talha Munir, Peter Hillmen, MBChB, PhD, Stephen John Richards, PhD FRCPath, Robert Ariens, BSc, PhD, Anita Hill, MBChB (Hons), PhD

Blood (2017) 130 (Supplement 1): 462.

https://doi.org/10.1182/blood.V130.Suppl_1.462.462

Published: 2017

Journal Articles

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Shannon L. Meeks, MD, Courtney Cox, MSc, W. Hunter Baldwin, BS

Blood (2017) 130 (Supplement 1): 2364.

https://doi.org/10.1182/blood.V130.Suppl_1.2364.2364

Published: 2017

Journal Articles

Altered Expression of Pdgfrα and Its Downstream Signalling Components May be Causal in the Development of Imatinib Induced Thrombocytopenia in CML Patients Receiving Imatinib Treatment

Sameer Ahmad Guru, Musadiq Ahmad Bhat, MSc., Imtiyaz Ahmad Najar, PhD, Ab. Rashid Rashid, PhD, Mariyam Zuberi, PhD, Mamta Sumi Sumi, PhD, Naresh Gupta, MD, Alpana Saxena, Ajay Sharma, MD

Blood (2017) 130 (Supplement 1): 1627.

https://doi.org/10.1182/blood.V130.Suppl_1.1627.1627

Published: 2017

Journal Articles

Associations of Cholecalciferol Supplementation with Thrombin Generation and Fibrin Clot Structure in Severe Vitamin D Deficiency: A Prospective Cohort Study

Marc Blondon, MD MS, Emmanuel Biver, Olivia Braillard, Marc Righini, MD, Pierre Fontana, MD PhD, Alessandro Casini

Blood (2017) 130 (Supplement 1): 2374.

https://doi.org/10.1182/blood.V130.Suppl_1.2374.2374

Published: 2017

Journal Articles

High-Throughput Validation of Mutations Identified in Primary Leukemia Cells

Michelle Degnin, BASc, Cristina E. Tognon, Christopher A. Eide, Beth Wilmot, Shannon K. McWeeney, Daniel Bottomly, Rebecca Smith, BASc, Brian J. Druker

Blood (2016) 128 (22): 4725.

https://doi.org/10.1182/blood.V128.22.4725.4725

Published: 2016

Journal Articles

HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy

Malgorzata Bobrowicz, MSc, Joanna Stachura, MSc, Michal Dwojak, DMD, Antoni Domagala, MD, Beata Pyrzynska, PhD, Elise Berthel, MSc, Nicole Dalla Venezia, PhD, Marta Siernicka, MSc, Malgorzata Firczuk, PhD, Magdalena Winiarska, PhD

Blood (2016) 128 (22): 1586.

https://doi.org/10.1182/blood.V128.22.1586.1586

Published: 2016

Journal Articles

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Carter Thomas Davis, MD, Arati V. Rao, MD, Eross Guadalupe, Dale J. Christensen, PhD, J. Brice Weinberg, MD

Blood (2016) 128 (22): 5126.

https://doi.org/10.1182/blood.V128.22.5126.5126

Published: 2016

Journal Articles

Characterization of Factor VIII Immune Complexes By Analytical Ultracentrifugation

Pete Lollar, MD, Ernest T. Parker, John F. Healey, Christopher B. Doering, PhD

Blood (2016) 128 (22): 3787.

https://doi.org/10.1182/blood.V128.22.3787.3787

Published: 2016

Journal Articles

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

Eriko Morishita, MD PhD, Mao Takata, BSc, Fumina Taniguchi, BSc, Masashi Akiyama, PhD, Akiko Sekiya, PhD, Akira Takagi, PhD, Toshiyuki Miyata, PhD, Tetsuhito Kojima, MD PhD

Blood (2016) 128 (22): 2574.

https://doi.org/10.1182/blood.V128.22.2574.2574

Published: 2016

NARROW

Heme Overload Triggers Xanthine Oxidase Release and Mediates the Inflammatory Response

The Immunomodulatory Effect of Triptolide on Mesenchymal Stem Cells in Vitro

The Factor VIII Variant X5 Enhances Hemophilia a Gene Therapy Efficiency By Its Improved Secretion

A Direct Oral Anticoagulant Edoxaban Enhanced Fibrinolysis Via Inhibition of Thrombin-Activatable Fibrinolysis Inhibitor Activation and Enhancement of Plasmin Generation in Human Plasma

An Alternative Pathway Specific Flow Cytometric Assay to Detect Complement Activation in Atypical Hemolytic Uremic Syndrome (aHUS)

Prediction of Anti-FVIII Inhibitor Persistence By Anti-FVIII IgG Subclasses in Patients with Severe Hemophilia — A in the Sippet Cohort Study

Histones Induce the Release of Extracellular Hemoglobin and Red Blood Cell-Derived Microvesicles with Procoagulant Activity

Intravascular Cells and Circulating Microparticles Induce Procoagulant Activity Via Phosphatidylserine Exposure in Venous Thromboembolism and Contribute to Altered Plasma Fibrin Clot Properties

A Plasma-Based Assay to Measure the Susceptibility of Factor V(a) to Inhibition By TFPIα

Lesional Mechanism of Alpha Thalassemias : Towards a Common Mechanism Alpha Thal / Beta Thal

The Hypofibrinolytic Defect of Nephrotic Syndrome Is Directly Proportional to Disease Severity

Fibrinogen and Clot Structure Is Affected By Eculizumab in Patients with Paroxysmal Nocturnal Haemoglobinuria

Epitope Mapping of Inhibitor Patient Plasmas during Immune Tolerance Induction

Altered Expression of Pdgfrα and Its Downstream Signalling Components May be Causal in the Development of Imatinib Induced Thrombocytopenia in CML Patients Receiving Imatinib Treatment

Associations of Cholecalciferol Supplementation with Thrombin Generation and Fibrin Clot Structure in Severe Vitamin D Deficiency: A Prospective Cohort Study

High-Throughput Validation of Mutations Identified in Primary Leukemia Cells

HDAC6 Inhibition Increases Translation of CD20 mRNA and Potentiates the Efficacy of Anti-CD20 Immunotherapy

Fingolimod Is Cytotoxic in Acute Myeloid Leukemia Independent of Additional Chemotherapeutic Agents

Characterization of Factor VIII Immune Complexes By Analytical Ultracentrifugation

Asymptomatic Dysprothrombinemia (Prothtombin Himi) with p.M380T and p.R431H Shows Severely Reduced Clotting Activity, Moderate Antithrombin Resistance and Severe Thrombomodulin Binding Defect

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only